致心律失常性右室心肌病与运动:从分子通路到运动员心脏鉴别
本文综述了体育锻炼在致心律失常性右室心肌病(ARVC)中诱导心脏结构改变的分子相互作用,以及运动对ARVC患者心律失常发生和其他临床后果的影响。文章指出运动是ARVC表型表达、心律失常风险和疾病进展的强决定因素,现行指南建议ARVC患者不应参与竞技性或频繁高强度耐力运动。运动诱导的生理性重塑(运动员心脏)可模仿ARVC的经典特征,使当前国际工作组诊断标准在运动员中可能表现不佳,鉴别两者常具挑战性,假阳性和假阴性均不可接受。
要点
- 运动是ARVC表型表达、心律失常风险和疾病进展的强决定因素。
- 现行指南建议ARVC患者不应参与竞技性或频繁高强度耐力运动。
- 运动员心脏可模仿ARVC特征,当前诊断标准在运动员中可能表现不佳。
核心结论
- 运动是ARVC表型表达、心律失常风险和疾病进展的强决定因素。
- 运动员心脏可模仿ARVC经典特征,使鉴别诊断困难,假阳性和假阴性均不可接受。
研究设计与样本
- 综述,总结运动诱导心脏结构改变的分子相互作用及运动对ARVC患者心律失常发生和其他临床后果的影响。
主要发现
- 运动诱导的电学和形态学生理性重塑(运动员心脏)可模仿ARVC的若干经典特征。
- 当前国际工作组诊断标准在运动员中可能表现不佳。
关键数值与推荐
- 现行指南建议ARVC患者不应参与竞技性或频繁高强度耐力运动。
- 当前国际工作组诊断标准可能不适用于运动员。
临床怎么用
- 临床医生需在运动员中鉴别ARVC与运动员心脏,避免假阳性导致不必要治疗和假阴性使患者失去保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease associated with a high risk of sudden cardiac death. Among other factors, physical exercise has been clearly identified as a strong determinant of phenotypic expression of the disease, arrhythmia risk, and disease progression. Because of this, current guidelines advise that individuals with ARVC should not participate in competitive or frequent high-intensity endurance exercise. Exercise-induced electrical and morphological para-physiological remodelling (the so-called 'athlete's heart') may mimic several of the classic features of ARVC. Therefore, the current International Task Force Criteria for disease diagnosis may not perform as well in athletes. Clear adjudication between the two conditions is often a real challenge, with false positives, that may lead to unnecessary treatments, and false negatives, which may leave patients unprotected, both of which are equally inacceptable. This review aims to summarize the molecular interactions caused by physical activity in inducing cardiac structural alterations, and the impact of sports on arrhythmia occurrence and other clinical consequences in patients with ARVC, and help the physicians in setting the two conditions apart.
引用
- Gasperetti A, James CA, Cerrone M, et al. Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry. Eur Heart J. 2021. PMID: 33200174. doi:10.1093/eurheartj/ehaa821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。